Inventor
Israel Vlodavsky
Inventor
Mevaseret Zion, IL
Overview
Patents· 39 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes17%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations14%
C12NMicroorganisms or enzymes14%
C12YEnzymes14%
C07KPeptides13%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
A61MDevices for introducing media into, or onto, the body6%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
A61LMethods or apparatus for sterilising materials or objects in general3%
PatentTitleYear
10,302,662Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders20199,428,586'Heparanase splice variant'20169,366,684'Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation related disorders'20168,853,387'Mimetics of sulfated oligosaccharides'20148,809,620'Heparanase deficient non-human mammals'20148,093,031'Heparanases and splice variants thereof, polynucleotides encoding them and uses thereof'20128,048,993'Heparanase specific molecular probes and their use in research and medical applications'20117,790,376'Heparanase specific molecular probes and their use in research and medical applications'20107,772,187'Substances directed against a specific sequence essential for heparanase catalytic activity and uses thereof as heparanase inhibitors'20107,666,651'Polypeptide having heparanase activity'20107,339,038'Heparanase specific molecular probes and their use in research and medical applications'2008RE039574'Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies'20077,049,407'Heparanase specific antibodies and their use in research and medical applications'20066,986,996'Heparanase specific molecular probes and their use in research and medical applications'20066,960,471'Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells'20056,946,131'Heparanase activity neutralizing anti-heparanase monoclonal antibody'20056,800,441'Heparanase specific molecular probes and their use in research and medical applications'20046,790,658'Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells'20046,699,672'Heparanase specific molecular probes and their use research and medical applications'20046,677,137'Avian and reptile derived polynucleotide encoding a polypeptide having heparanase activity'20046,664,105'Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells'20036,589,782'Angiogenic factor and use thereof in treating cardiovascular disease'20036,583,276'Angiogenic factors and use thereof in treating cardiovascular disease'20036,562,950'Heparanase activity neutralizing anti-heparanase monoclonal antibody'20036,531,129'Heparanase specific molecular probes and their use in research and medical applications'20036,420,371'Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies'20026,190,875'Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe'20016,177,545'Heparanase specific molecular probes and their use in research and medical applications'20016,159,488'Intracoronary stents containing quinazolinone derivatives'20006,090,814'Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization'20006,028,075'Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies'20006,013,780'VEGF.sub.145 expression vectors'20005,998,422'Quinazolinone-containing pharmaceutical compositions and methods for the use thereof'19995,997,863'Attenuation of wound healing processes'19995,968,822'Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells'19995,891,879'Quinazolinone-containing pharmaceutical compositions and methods for the use thereof'19995,362,641'Heparanase derived from human Sk-Hep-1 cell line'19945,206,223'Method for inhibiting heparanase activity'19934,882,318'Method for decreasing tumor metastasis'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–1999Based in Jerusalem, IL· patent location history
1994Based in Har Gilo, IL· patent location history
1999–2011Patents assigned to HADASIT MED RES SERVICE (18)· patent assignee history
1999–2007Patents assigned to AGRICULTURAL RES ORG (4)· patent assignee history
1999–2016Based in Mevaseret Zion, IL· patent location history
2001–2004Patents assigned to INSIGHT STRATEGY & MARKETING (6)· patent assignee history
2001–2014Based in Mevasseret Zion, IL· patent location history
2004–2011Patents assigned to INSIGHT BIOPHARMACEUTICALS LTD (7)· patent assignee history
2012–2016Patents assigned to VLODAVSKY ISRAEL (5)· patent assignee history
2014–2019Based in Haifa, IL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HADASIT MED RES SERVICE | 18 | 1999–2011 |
| INSIGHT BIOPHARMACEUTICALS LTD | 7 | 2004–2011 |
| INSIGHT STRATEGY & MARKETING | 6 | 2001–2004 |
| VLODAVSKY ISRAELself | 5 | 2012–2016 |
| AGRICULTURAL RES ORG | 4 | 1999–2007 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mevaseret Zion, IL | 26 | 1999–2016 |
| Mevasseret Zion, IL | 6 | 2001–2014 |
| Haifa, IL | 3 | 2014–2019 |
| Jerusalem, IL | 3 | 1989–1999 |
| Har Gilo, IL | 1 | 1994 |